Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field.
March 09, 2023
We hope to see you at ENDO 2023, taking place June 15-18, 2023, in Chicago, Illinois. With over 7,000 attendees, nearly 2,000 abstracts and over 200 other sessions, ENDO is the top global meeting on endocrinology research and clinical care. ENDO provides the opportunity to collaborate with an unparalleled list of endocrinologists, health care practitioners, and scientists that lead our field. Register Today!
March 09, 2023
We invite you to enter our 2023 Endocrine Images Art Competition and share your most spectacular endocrine images with scientists and researchers from all over the world.
March 14, 2023
Read our special collection of journal articles, published in 2021–2023, describing research on endocrine-disrupting chemicals! Curation of the collection was guided by Altmetric Attention Scores and Featured Article designations.
.jpg)
March 16, 2023
The Endocrine Self-Assessment Program (ESAP™) 2023 is essential for professional development and staying up to date with the best practices in endocrinology. This program features 120 clinical cases, customized performance reports, and two learning modes. Earn up to 40.0 AMA PRA Category 1 Credits™ and 40.0 ABIM MOC points. Order now!
March 17, 2023
Endocrine Society advocacy leads to EDC regulation in the United States and the European Union.
Need more info?
Learn more about the advantages of membership
March 21, 2023
Women with obesity may share risk for the disease with their daughters, but not their sons, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
March 14, 2023
The Endocrine Society supports a new U.S. Environmental Protection Agency (EPA) rule which includes provisions to regulate several per- and polyfluoroalkyl substances (PFAS)—including PFOA and PFOS—found in our drinking water.
March 14, 2023
A broad coalition of over 30.000 European and international endocrine experts have today called on EU legislators to publish the revised REACH proposal without any further delay and no later than June 2023.
March 21, 2023
The authors report 2 Japanese infants with hypothyroidism requiring levothyroxine replacement therapy following exposure to iodinated contrast media.
March 21, 2023
We review recent work and ideas concerning the involvement of adrenal steroids in treatment resistance in prostate and breast cancers.
March 21, 2023
We investigated the impact of critical illness on muscular expression of irisin, kynurenine aminotransferases, and amylase; association with clinical outcome; and impact of interventions that attenuate muscle wasting/weakness.
